Vinvik Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 21-05-2024
- Paid Up Capital ₹ 0.10 M
as on 21-05-2024
- Company Age 22 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.50 M
as on 21-05-2024
- Revenue -4.50%
(FY 2020)
- Profit -32.43%
(FY 2020)
- Ebitda 12.74%
(FY 2020)
- Net Worth 16.20%
(FY 2020)
- Total Assets 30.74%
(FY 2020)
About Vinvik Pharma
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.50 M.
Ram Gupta, Rashmi Goyal, and Vikas Bansal serve as directors at the Company.
- CIN/LLPIN
U24239HR2002PTC034990
- Company No.
034990
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Nov 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurgaon, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vinvik Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram Gupta  | Additional Director | 02-Jun-2008 | Current |
| Rashmi Goyal | Additional Director | 02-Jun-2008 | Current |
| Vikas Bansal | Director | 14-Nov-2002 | Current |
Financial Performance of Vinvik Pharma.
Vinvik Pharma Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 4.5% decrease. The company also saw a substantial fall in profitability, with a 32.43% decrease in profit. The company's net worth Soared by an impressive increase of 16.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vinvik Pharma?
In 2017, Vinvik Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Oct 2022 | ₹0.50 M | Open |
How Many Employees Work at Vinvik Pharma?
Unlock and access historical data on people associated with Vinvik Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vinvik Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vinvik Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
